AstraZeneca will invest 50 billion dollars to expand manufacturing and research in the US, including a new plant in Virginia for anti-obesity treatments.
Gabriel Dumitrache
International
Foto: Shutterstock
Always see our news on Google
Pharmaceutical company AstraZeneca has announced a $50 billion investment in the US, aiming to expand manufacturing and research capabilities by 2030. A new facility in Virginia will produce treatments for weight and metabolic diseases, including an anti-obesity drug. This investment will create tens of thousands of jobs and reflects the company's confidence in American biopharmaceutical innovation. AstraZeneca is focusing its strategy on the U.S. market, which generated more than 40% of its revenue in 2024. The move aligns with industry trends, where other large companies are stepping up investments in the US.
Sources
AstraZeneca va investi 50 de miliarde de dolari în SUA până în 2030, pe fondul presiunilor tarifare din sectorul farmaceutic
AstraZeneca anunță că va investi 50 de miliarde de dolari în SUA până în 2030, pe fondul presiunilor tarifare
AstraZeneca va investi 50 de miliarde de dolari în SUA până în 2030, pe fondul presiunilor tarifare din sectorul farmaceutic
AstraZeneca to invest $50 bn in the US as tariff threat looms
Strategia companiilor europene pentru a-l calma pe Trump: AstraZeneca anunță o investiție masivă în SUA
AstraZeneca to invest $50bn in US by 2030 amid Trump tariff threats
AstraZeneca says to invest $50 bn in the US
AstraZeneca unveils $50bn US investment as pharma tariff threat looms - business live
AstraZeneca va investi 50 de miliarde de dolari în SUA până în 2030, pe fondul presiunilor tarifare din sectorul farmaceutic
Latest News
21:57
Alexandru Nazare estimates the beginning of deflation this autumn.
21:39
Volodymyr Zelensky will make a visit to Serbia on Saturday, marking his first trip to this country since the beginning of the Russian invasion.
21:35
The authorities in Turkey announced the discovery of a statue group in Aspendos, representing the god of medicine Asklepios and his son Telesphoros.
21:19
France prohibits unsolicited commercial calls: fines of up to 375,000 euros for companies
21:09
Minister Irineu Darău initiated a dialogue with the management of companies and unions in the defense industry to identify solutions for increasing competitiveness.
See more news
NEWS ON THE SAME TOPICS
International
AstraZeneca, negotiations with Bristol Myers Squibb for a possible merger that could create a 400 billion dollar group
International
AstraZeneca announced the failure of a drug for a rare heart condition, causing a 9% drop in the company's shares.
.webp)
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
